KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查 入排置信度 0.85

[Multimodality treatment in high-risk and very high-risk prostate cancer: outcomes from international phase III randomized controlled trials].

Etienne Mathier, Astrid Heusel, Mohamed Shelan

Strahlenther Onkol 198(10) 962-965

PMID35732920
PMCID-
DOI10.1007/s00066-022-01968-5
发表日期2022-06-22
入排依据:While the record meets criteria for oncology, human, randomized, Phase III, and original result, it lacks explicit evidence of a drug intervention and a time-to-event efficacy endpoint from the provided metadata. Therefore, it is not eligible.
摘要

摘要

无摘要

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。